Understanding how the immune system responds to biotherapeutic drugs is essential for predicting their safety and effectiveness. Some patients will develop anti-drug antibodies (ADA) that can change h
Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promot
SAE Information Page 1 Details Study Description This was a multi-center, prospective, open-label, pharmacokinetic (PK) and safety study of anti-epileptic drugs in obese children age 2 to less than 18